Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3 Hepatitis C Virus”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02822794
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 117
Testing effectiveness (Phase 2)Study completedNCT01958281
What this trial is testing

Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency

Who this might be right for
HCV Infection
Gilead Sciences 38
Large-scale testing (Phase 3)Study completedNCT02114151
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 103
Testing effectiveness (Phase 2)Study completedNCT01858766
What this trial is testing

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 379
Post-approval studies (Phase 4)Study completedNCT02087111
What this trial is testing

Telaprevir in Genotype 3 HCV

Who this might be right for
Hepatitis C
Queen Mary University of London 14
Large-scale testing (Phase 3)Study completedNCT01896193
What this trial is testing

Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 127
Large-scale testing (Phase 3)Study completedNCT02073656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Who this might be right for
Hepatitis C VirusHIV
Gilead Sciences 335
Large-scale testing (Phase 3)Study completedNCT01625338
What this trial is testing

Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 534
Testing effectiveness (Phase 2)Study completedNCT01215643
What this trial is testing

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

Who this might be right for
Hepatitis CChronic Pain
Debiopharm International SA 340
Not applicableEnded earlyNCT01100749
What this trial is testing

Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

Who this might be right for
Chronic Hepatitis C - Genotype 3
University Health Network, Toronto 25
Post-approval studies (Phase 4)Study completedNCT02304159
What this trial is testing

Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics

Who this might be right for
Hepatitis CCirrhosis
Tarek I. Hassanein, M.D., FACP, FAG, AGAF 39
Large-scale testing (Phase 3)Study completedNCT01241760
What this trial is testing

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Genotype 1 Chronic Hepatitis CTreatment Naive
Janssen Infectious Diseases BVBA 744
Large-scale testing (Phase 3)Study completedNCT01682720
What this trial is testing

Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 421
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Early research (Phase 1)Study completedNCT01590407
What this trial is testing

First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 71
Testing effectiveness (Phase 2)Study completedNCT00863239
What this trial is testing

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT02332720
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 413
Large-scale testing (Phase 3)Study completedNCT02243293
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C Virus
AbbVie 694
Large-scale testing (Phase 3)Study completedNCT01542788
What this trial is testing

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 278
Not applicableUnknownNCT03510637
What this trial is testing

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 7,500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation